Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTR20160922Phase 3Completed
A Phase 3 trial of esketamine, sponsored by Hengrui Therapeutics. Started Dec 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on CTR20160922.